Related Experiment Videos
Serum isocitrate dehydrogenase activity in Reye's syndrome
Biochemical Medicine and Metabolic Biology
|April 1, 1987
Summary
Serum isocitrate dehydrogenase levels were measured in Reye's syndrome patients. Elevated enzyme levels were observed in most patients but showed no direct correlation with clinical parameters or disease stage.
Area of Science:
- Biochemistry
- Pediatric Medicine
- Enzymology
Background:
- Reye's syndrome is a severe, potentially fatal condition affecting children and adolescents.
- Enzyme levels in serum can serve as biomarkers for various medical conditions.
- Isocitrate dehydrogenase (IDH) is an enzyme involved in cellular metabolism.
Purpose of the Study:
- To investigate serum isocitrate dehydrogenase (IDH) levels in patients with Reye's syndrome.
- To compare IDH levels with other biochemical markers and clinical parameters in Reye's syndrome.
Main Methods:
- Serum samples were collected from 12 patients diagnosed with Reye's syndrome.
- Serum levels of isocitrate dehydrogenase (IDH) were quantified.
- IDH levels were compared with serum ornithine carbamyl phosphate, glutamic oxaloacetic transaminase (aspartate aminotransferase), and ammonia.
- Enzyme levels were also correlated with the clinical stages of Reye's syndrome.
Main Results:
- Elevated serum isocitrate dehydrogenase (IDH) levels were detected in 8 out of 12 Reye's syndrome patients.
- No direct correlation was found between elevated serum IDH levels and other measured clinical parameters.
- The study did not establish a clear relationship between IDH levels and the severity or stage of Reye's syndrome.
Conclusions:
- Serum isocitrate dehydrogenase (IDH) may be elevated in Reye's syndrome patients.
- Elevated IDH levels do not appear to correlate with other biochemical markers or clinical parameters in this patient cohort.
- Further research is needed to elucidate the role of IDH in the pathophysiology of Reye's syndrome.